These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7713552)
41. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India. Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718 [TBL] [Abstract][Full Text] [Related]
42. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy. Job CK; Jayakumar J; Aschhoff M; Mathan MM Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112 [TBL] [Abstract][Full Text] [Related]
43. Comparison between microsatellites and Ml MntH gene as targets to identify Mycobacterium leprae by PCR in leprosy. Cruz AF; Furini RB; Roselino AM An Bras Dermatol; 2011; 86(4):651-6. PubMed ID: 21987128 [TBL] [Abstract][Full Text] [Related]
44. Detection of Mycobacterium leprae DNA in skin lesions of leprosy patients by PCR may be affected by amplicon size. Goulart IM; Cardoso AM; Santos MS; Gonçalves MA; Pereira JE; Goulart LR Arch Dermatol Res; 2007 Aug; 299(5-6):267-71. PubMed ID: 17530267 [TBL] [Abstract][Full Text] [Related]
45. Study of multidrug therapy in paucibacillary leprosy. Kar PK; Sohi AS J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283 [TBL] [Abstract][Full Text] [Related]
46. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. Nathan CF; Kaplan G; Levis WR; Nusrat A; Witmer MD; Sherwin SA; Job CK; Horowitz CR; Steinman RM; Cohn ZA N Engl J Med; 1986 Jul; 315(1):6-15. PubMed ID: 3086725 [TBL] [Abstract][Full Text] [Related]
47. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy. Shetty VP; Suchitra K; Uplekar MW; Antia NH Lepr Rev; 1997 Jun; 68(2):131-8. PubMed ID: 9217352 [TBL] [Abstract][Full Text] [Related]
49. Use of PCR-mediated amplification of Mycobacterium leprae DNA in different types of clinical samples for the diagnosis of leprosy. Santos AR; De Miranda AB; Sarno EN; Suffys PN; Degrave WM J Med Microbiol; 1993 Oct; 39(4):298-304. PubMed ID: 8411091 [TBL] [Abstract][Full Text] [Related]
50. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355 [TBL] [Abstract][Full Text] [Related]
51. Bacillaemia in leprosy and effect of multidrug therapy. Chatterjee G; Kaur S; Sharma VK; Vaishnavi C; Ganguly NK Lepr Rev; 1989 Sep; 60(3):197-201. PubMed ID: 2682105 [TBL] [Abstract][Full Text] [Related]
52. Association of the mycobacterial 30-kDa region proteins with the cutaneous infiltrates of leprosy lesions. Evidence for the involvement of the major mycobacterial secreted proteins in the local immune response of leprosy. Rambukkana A; Das PK; Krieg S; Faber WR Scand J Immunol; 1992 Jul; 36(1):35-48. PubMed ID: 1615282 [TBL] [Abstract][Full Text] [Related]
53. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up. Rao PN; Suneetha S; Pratap DV Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932 [TBL] [Abstract][Full Text] [Related]
54. Detection of Mycobacterium leprae in nasal mucosa biopsies by the polymerase chain reaction. Patrocínio LG; Goulart IM; Goulart LR; Patrocínio JA; Ferreira FR; Fleury RN FEMS Immunol Med Microbiol; 2005 Jun; 44(3):311-6. PubMed ID: 15907454 [TBL] [Abstract][Full Text] [Related]
55. Polymerase chain reaction assay for the detection and identification of Mycobacterium leprae in patients in the United States. Scollard DM; Gillis TP; Williams DL Am J Clin Pathol; 1998 May; 109(5):642-6. PubMed ID: 9576586 [TBL] [Abstract][Full Text] [Related]
56. Ultrastructural alterations of mycobacterium leprae in skin biopsies of untreated and treated lepromatous patients. Silva MT; Macedo PM; Costa MH; Gonçalves H; Torgal J; David HL Ann Microbiol (Paris); 1982; 133(1):75-92. PubMed ID: 7051933 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of diagnostic role of in situ PCR on slit-skin smears in pediatric leprosy. Kamal R; Natrajan M; Katoch K; Katoch VM Indian J Lepr; 2010; 82(4):195-200. PubMed ID: 21434596 [TBL] [Abstract][Full Text] [Related]
58. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy. Kamal R; Dayal R; Katoch VM; Katoch K Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070 [TBL] [Abstract][Full Text] [Related]
59. Typing of Thai clinical isolates of Mycobacterium leprae and analysis of leprosy transmission by polymorphism of tandem repeats. Srisungngam S; Rudeeaneksin J; Wattanpokayakit S; Pasadorn S; Tragoolpua R; Suwanrit S; Sawanpanyalert P; Phetsuksiri B Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):714-20. PubMed ID: 17883012 [TBL] [Abstract][Full Text] [Related]